Serum amyloid A protein (SAA) is a major acute-phase protein in humans and most other mammals. In addition, it is the serum precursor of the major protein constituent of reactive amyloid fibrils. Sequence analyses have identified a number of polymorphic forms of human SAA and amyloid A protein (AA), but the question of the number of genes encoding SAA in the human has not been addressed. In addition, there are insufficient data to predict whether one form of SAA predisposes to amyloid fibril formation. In the present study three separate SAA proteins have been isolated from the plasma of one individual and completely sequenced. While two of the SAA forms (SAA2a and SAA2,6) differ from each other only at position 71, they differ from the most abundant form (SAA1) at seven and eight other positions, respectively. Nucleotide sequencing of cDNAs from a liver library of this individual identified all three mRNAs coding for these proteins and proved that: (a) the often-reported absence of arginine at the amino terminus of SAA proteins must result from proteolytic processing of the protein; (b) the polymorphism involving histidine and arginine at position 71 is present at the DNA level and therefore is not due to an event at the translational level; (c) there are at least two genes coding for human SAA. Comparison of these data to published sequences of SAA and AA proteins may help in identifying genetically determined forms of SAA which predispose to reactive amyloid fibril formation.
Introduction
Reactive amyloidosis is a fatal condition characterized by extracellular protein deposition in patients with chronic inflammatory diseases. It also develops in a high percentage of individuals with familial Mediterranean fever, an autosomal recessive disease most prevalent in Sephardic Jews, Arabs, and Turks. While a genetic pattern of amyloidosis has not been noted among patients with chronic diseases, its frequent association with familial Mediterranean fever suggests that genetic factors may be involved in its pathogenesis. Such factor(s) could explain the relatively low incidence of amyloidosis seen in American patients with chronic inflammatory diseases.
Amyloid fibrils which form the deposits in reactive amyloidosis are composed primarily of amyloid A protein (AA),' a degradation product ofthe acute-phase protein serum amyloid A (SAA). It is commonly hypothesized that increased synthesis of SAA during inflammatory conditions contributes to the development of amyloidosis. High blood concentrations of SAA, however, are seen in most patients with infection and inflammation without resultant amyloid deposition. Thus it appears that additional factors such as metabolic variations, protein processing, and structural gene polymorphisms may influence the likelihood for developing this disease.
An important role for SAA structure in amyloid fibril formation has been suggested by the finding that two major forms of SAA are present in the mouse, but only one form is incorporated into amyloid deposits (1) . Because humans represent an exceedingly complex population relative to inbred mouse strains, more human SAA and AA molecules will have to be structurally characterized to evaluate the possibility of selective deposition. To investigate the importance of the primary structure of SAA proteins in amyloidogenesis, we have studied the forms of this protein in one individual at both the DNA and protein levels.
Methods
Cloning and sequence determination ofSAA cDNAs. Liver tissue was obtained at the time of organ donation from patient COL, a man who had suffered accidental traumatic injury. Poly A' RNA isolated from this liver served as the template for the synthesis of cDNA. The cDNA was ligated into the PstI site of pBR322 which, in turn, was used to transform Escherichia coli HB1O1 cells. The exact procedures used to construct and the conditions used to screen this library have been described (2) . The size ofthe cDNA inserts was determined and restriction analysis carried out using recombinant plasmid DNA prepared according to the rapid alkaline lysis method (3). For sequence analysis, recombinant plasmid DNA was generated on a larger scale (4) and further purified by ultracentrifugation through ethidium bromide-cesium chloride gradients.
Sequence determination ofSAA2f cDNA was accomplished by the chain termination method (6) 
Results
Selection and sequence determination of three distinct SAA cDNA clones. Three distinct SAA cDNA clones, designated pSAA 1, pSAA2a, and pSAA2fl, were isolated from the cDNA library constructed using poly A' RNA extracted from a single liver. The cloning and sequence determination of pSAA2a (previously referred to as pSAA82) has been described (2) . The cDNA inserts of the three clones were readily distinguished from each other by the particular cleavage pattern which resulted from digestion with PstI and NcoI (Fig. 1 ). SAA 1 cDNA was cleaved internally by PstI as evidenced by its excision from pBR322 as two fragments; the larger of the two fragments was in turn cut by NcoI. SAA2a cDNA, excised as an intact fragment of -575 base pairs, was not cut internally by PstI; however, it was cleaved by NcoI. SAA2$ cDNA was not cut by either enzyme.
The nucleotide sequences determined for SAA1, SAA2a, and SAA2,B cDNAs confirm that they encode SAA and show that all three extend from a 5'-untranslated region through a poly A tail. SAA2a and SAA2,B cDNAs have identical nucleotide sequences within their coding regions except for the second position ofcodon 71, at which SAA2a cDNA has adenine and SAA2,B cDNA guanine (Fig. 2) . The underlined sequence CCATGG in SAA1 and SAA2a cDNAs encompasses codon 71 and is the recognition sequence for NcoI.
While the nucleotide sequence of SAA I cDNA differs from the sequences of SAA2a and SAA2f cDNAs at a number of positions, all but one of the polymorphic sites are in the 3'-half of the sequence (Fig. 2) . Single-base differences between SAA1 (Fig. 3) . Sequence analysis showed that two of the four forms, those present in peaks III and IV, were identical to each other, except for the presence of arginine at the amino terminus of one (peak III) and not the other (peak IV). The amino acid sequence of these forms was the same as that encoded by SAA 1 cDNA (Fig. 4) ; hence, peak III material has been designated SAA 1 and peak IV material SAA 1 des Arg. These two forms constituted the majority of SAA isolated from the donor's plasma. The sequences of the other two forms, isolated as peaks I and II (Fig. 3) , were also identical to each other, except that peak II material lacked arginine at the amino terminus. Both of these forms were composed of two SAA molecules differing by having either a histidine or an arginine residue at position 71. The histidine-containing sequence (SAA2a, Fig. 4) matched the amino acid sequence derived from SAA2a cDNA, while the arginine-containing sequence (SAA2#, Fig.  4 Interestingly, the three SAA protein sequences described in this report are the same as those isolated from another unrelated individual (11) . In both studies, all three forms were found with and without an amino-terminal arginine. The three cDNAs reported here and the SAA cDNA cloned by Sipe et al. (12) have a codon specifying arginine at the amino terminus. Therefore, the amino-terminal heterogeneity observed by us and reported by a number of investigators (13-15) most likely represents proteolytic processing rather than a genetically determined polymorphism.
A comparison of the three SAA structures in this individual shows that SAA2a and SAA2,3 have a single amino acid difference specified by a singe nucleotide change. They differ, however, from SAA 1 at a number of sites. Between the coding regions of SAA1 and SAA2a cDNAs there are 12 nucleotide differences of which 8 are replacement changes, that is, they result in amino acid differences. Between SAA 1 and SAA2/B cDNAs there are 13 nucleotide differences resulting in nine amino acid changes. This high rate of replacement changes compared to silent site changes also has been noted as an unusual feature of mouse SAA1 and SAA2 gene evolution. Lowell et al. (16) have proposed that the heterogeneous proteins resulting from replacement substitutions in the mouse SAA genes provide a selective advantage and thus have helped fix the genes in the population.
Ofthe three protein forms described here, SAAI appears to be the most common. This polymorph was the predominant form in our donor and also in another individual (1 1). Furthermore, its sequence matches the amino acid sequence derived from the cDNA characterized by Sipe et al. (12) and except for the lack of valine/alanine polymorphisms at positions 52 and 57, is identical to the amino acid sequence determined by Parmelee et al. (17) for SAA isolated from pooled human serum. The presence of phenylalanine at positions 68 and 69, glutamic acid at 84, and lysine at 90 in SAA1 also makes it similar to an SAA purified by Sletten et al. (18) from the plasma of a single individual, which unlike SAA 1, has asparagine rather than aspartic acid at positions 23, 60, and 75. The combination ofleucine at position 68 and threonine at 69, as occurs in SAA2a and SAA2,B, has been reported less frequently than phenylalanine at the same positions. Leucine and threonine at positions 68 and 69, as well as arginine at 71, were seen in the first completely sequenced AA protein which was isolated from a person with familial Mediterranean fever (19 
